In vitro Assessment of Drug Adsorption Profiles during Hemoadsorption Therapy
Blood Purification · 2025
DOI: 10.1159/000545120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2025. Verfasst von Andreas Körtge und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Extracorporeal Therapy Systems, Fraunhofer Institute for Cell Therapy and Immunology IZI, Rostock, Germany. Hauptthemen laut MEDLINE: Hemoperfusion, Hemofiltration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The use of hemoadsorption devices is increasingly gaining impact as an adjunct therapy for various critical conditions in ICU patients, including systemic hyperinflammation, cytokine release syndrome, sepsis, and more. A key concern in this therapy is its impact on the plasma levels of concurrently administered drugs, which could potentially be reduced to subtherapeutic levels, affecting patient care. The present study investigates the adsorption behavior of various drugs in an in vitro hemoadsorption model using human whole blood, aiming to provide insights for optimizing drug dosing during hemoadsorption therapy.
Methods
The study assessed the removal rates and clearances of several drugs, namely, apixaban, argatroban, carbamazepine, oxcarbazepine, lamotrigine, phenytoin, valproate, levosimendan, methylene blue, and metformin, by circulating the blood through CytoSorb adsorbers in an in vitro setup.
Results
Significant removal (75 to 100% of the initial concentration) and high initial plasma clearances (approximately 10–25 mL/min) were observed for most of the tested drugs within the first 30–60 min of recirculation. Lower removal rates and clearances were noted for valproate (approximately 40% and 5 mL/min) and metformin (approximately 15% and 1 mL/min).
Conclusion
The findings indicate considerable differences in the adsorption of the tested drugs and should be confirmed by additional in vivo studies with careful monitoring of drug levels throughout the course of therapy. Understanding the in vivo dynamics is crucial for adjusting dosages appropriately during hemoadsorption use to ensure therapeutic efficacy and patient safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Extracorporeal Therapy Systems, Fraunhofer Institute for Cell Therapy and Immunology IZI, Rostock, Germany.
- Division of Nephrology, Center for Internal Medicine, Rostock University Medical Center, Rostock, Germany.
- Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center, Rostock, Germany.
Zitieren
APA
Körtge, A., Kamper, C., Klinkmann, G., Wasserkort, R., & Mitzner, S. (2025). In vitro Assessment of Drug Adsorption Profiles during Hemoadsorption Therapy. Blood Purification. https://doi.org/10.1159/000545120
Vancouver
Körtge A, Kamper C, Klinkmann G, Wasserkort R, Mitzner S. In vitro Assessment of Drug Adsorption Profiles during Hemoadsorption Therapy. Blood Purification. 2025. doi:10.1159/000545120
BibTeX
@article{Krtge2025,
author = {Körtge, Andreas and Kamper, Christoph and Klinkmann, Gerd and Wasserkort, Reinhold and Mitzner, Steffen},
title = {In vitro Assessment of Drug Adsorption Profiles during Hemoadsorption Therapy},
journal = {Blood Purification},
year = {2025},
doi = {10.1159/000545120}
}
EUVIMED